To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France

NCT01291394 · clinicaltrials.gov ↗

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Disorders

Interventions

DEVICE: Easypod™

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]